MedPath

LIVTENCITY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

LIVTENCITY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1221672002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Nov 21, 2022

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1221672002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

MARIBAVIRActive
Quantity: 200 mg
Name: MARIBAVIR

ATC CLASSIFICATION (3)

J05A
J05AX
J05AX10

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.